Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system

Drugs Context. 2019 Mar 4:8:212569. doi: 10.7573/dic.212569. eCollection 2019.
No abstract available

Keywords: IPSS; primary myelofibrosis; ruxolitinib.

Publication types

  • Case Reports